Outcome of Board Meeting

September 02, 2026 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, P.J. Towers, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East) Mumbai - 400 001 Mumbai - 400 051 Scrip Code : 506109 Symbol : GENESYS Dear Sir/Madam, Subject: Outcome of Board Meeting held on September 02, 2026 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to hereby inform that the Board of Directors of the Company, at their meeting held on today i.e. Wednesday, September 02, 2026 have inter alia considered and approved the following: - 1. Appointment of Statutory Auditors Based on the recommendation of the Audit Committee, the Board of Directors of the Company, at its meeting held today, i.e., Wednesday, September 2, 2026, has approved, subject to the approval of the Members of the Company, the appointment of M/s. G. K. Choksi & Co., Chartered Accountants (Firm Registration No. 125442W), as the Statutory Auditors of the Company for a first term of five consecutive years, commencing from the conclusion of the ensuing 44th Annual General Meeting (“AGM”) until the conclusion of the 49th AGM of the Company. The proposed appointment is in place of M/s. MSKA & Associates, Chartered Accountants, the existing Statutory Auditors of the Company, whose term shall expire upon conclusion of the ensuing 44th AGM. 2. Approval of Genesys ESOP Scheme – 2026 Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the introduction of a new Employee Stock Option Scheme, namely, the “Genesys ESOP Scheme – 2026”, subject to the approval of the Members of the Company and such other statutory and regulatory approvals as may be required. Under the Genesys ESOP Scheme – 2026, it is proposed to grant employee stock options to eligible employees of the Company and/or its subsidiary company(ies), as may be permitted under the applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, from time to time. Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 The aggregate number of stock options proposed to be granted under the Scheme shall not exceed 30,00,000 (Thirty Lakh) stock options, with each option being exercisable into one equity share of the Company having a face value of ₹5/- each, aggregating to a nominal value of ₹1,50,00,000 (Rupees One Crore Fifty Lakh only), subject to the terms and conditions of the Scheme and applicable laws. 3. ESOP Grant adjustment due to rights issue corporate action The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee, has approved a fair and reasonable adjustment to the outstanding stock options granted under the Genesys ESOP Scheme – 2022, consequent to the Rights Issue undertaken by the Company, in accordance with the applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Accordingly, as part of the aforesaid adjustment and based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the grant of 1,82,640 additional stock options to the existing eligible option holders under the Genesys ESOP Scheme – 2022. Each stock option shall be convertible into one equity share of the Company having a face value of ₹5/- each, at an exercise price of ₹50/- per option, subject to the terms and conditions of the Scheme and applicable laws. 4. Resignation of Internal Auditor The Board of Directors took note of the resignation of M/s. H.C. Vora & Associates, Chartered Accountants, from the position of Internal Auditor of the Company, with effect from September 2, 2026. M/s. H.C. Vora & Associates had been appointed by the Board of Directors at its meeting held on May 29, 2026, to conduct the internal audit of the Company for the financial year 2026-27. 5. Appointment of Internal Auditor Based on the recommendation of the Audit Committee, the Board of Directors approved the appointment of M/s. XAG & Co., Chartered Accountants, as the Internal Auditor of the Company, pursuant to the provisions of Section 138 of the Companies Act, 2013, read with the rules made thereunder, with effect from September 2, 2026. 6. AGM Notice The Board approved and adopted the Notice convening the 44th Annual General Meeting, and approved the convening of the 44th Annual General Meeting ("AGM") of the Company on Friday, September 30, 2026, at 03:30 P.M. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"), in accordance with the applicable provisions of the Companies Act, 2013 and the circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 The details as required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as Annexure – A. The meeting of Board commenced at 17:13 p.m. and concluded at 17:40 p.m. You are requested to take the above on your records. Thanking You, Yours faithfully, For Genesys International Corporation Limited Kushal Jain Company Secretary & Compliance Officer Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 Annexure-A The details as required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as Annexure – A. Disclosure Brief Particulars Appointment of M/s. Resignation of M/s. Appointment of M/s. G. K. XAG & Co., Chartered H.C. Vora & Details of Events Choksi & Co., Chartered Accountants, as the Associates, Chartered that need to be Accountants, as the Internal Auditor of Accountants as provided Statutory Auditors of the the Company. Internal Auditor of Company. the Company 1. Reason for change Appointment of M/s. G. K. Appointment of M/s. The resignation is viz. appointment, Choksi & Co., Chartered XAG & Co., Chartered being tendered resignation, Accountants, (Firm Accountants, as the consequent to the reappointment, Registration No. 125442W), Internal Auditor of the proposed removal, death or as the Statutory Auditors of Company. appointment of M/s G.K.Choksi & Co., otherwise; the Company. Chartered Accountants, (firm in The present term of existing which I am a Statutory Auditors, viz., partner) as the M/s. MSKA & Associates, Statutory Auditor of Chartered Accountants, is the Company. valid till the conclusion of In view of the the ensuing 44th Annual statutory audit General Meeting. engagement and the requirements relating to auditor independence, I consider it appropriate to relinquish the internal audit assignment with effect from the aforesaid date. Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 2. Date of Date of Appointment: Date of Date of Cessation: appointment September 02, 2026 Appointment: September 02, 2026 /cessation as September 02, 2026 applicable) & term Term of Appointment: of appointment; M/s. G. K. Choksi & Co., Term of Chartered Accountants LLP Appointment: will [Showing first 8,000 characters — download PDF for full document]